A carregar...
Non-factor replacement therapy for haemophilia: a current update
One of the most challenging issues facing us in the treatment of haemophilia is the development of alloantibodies against infused factor VIII (FVIII) or factor IX (FIX). Inhibitors render factor replacement therapy ineffective, exposing patients to an unacceptably high risk of morbidity and mortalit...
Na minha lista:
| Publicado no: | Blood Transfus |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Edizioni SIMTI - SIMTI Servizi Srl
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6125230/ https://ncbi.nlm.nih.gov/pubmed/29517971 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2450/2018.0272-17 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|